The signal transduction protein STAT5 serves as a negative regulator of BCL6 in lymphomas (46), and FoxO3a promotes BCL6 expression in leukemia cells exposed to BCR-ABLi (44, 47). This evidence concerns the gene BCL6 and lymphoma.